Heart arrhythmias may reduce blood flow to various parts of the body. In some instances, arrhythmias results in a Sudden Cardiac Arrest (SCA) where a person's heart suddenly and unexpectedly stops beating. If this occurs, blood may stop flowing to the brain and other vital organs. SCA can lead to death very quickly, within minutes, unless action is taken quickly.
Some people have an increased risk of SCA. This includes people who have had a heart attack, a prior SCA episode, among other risk factors. Frequently, these people are recommended for an Implantable Cardioverter Defibrillator (“ICD”). The ICD is a small electronic device connected to the heart that continuously monitors the person's electrocardiogram (“ECG”). If or when the ICD detects certain types of heart arrhythmias or abnormalities, then the ICD delivers an electric pulse or shock to the heart.
A patient may have a period of time between being recommended for an ICD and actually receiving one. In the interim timeframe, a patient may be suited with a wearable cardioverter defibrillator (“WCD”) system. A WCD system is worn by the patient and includes, among other components, a defibrillator and one or more external electrodes. When a patient wears a WCD system, the WCD may monitor several patient parameters, including the patient's ECG. If a potentially life threatening arrhythmia is detected, the defibrillator may be activated and primed to deliver an appropriate electric shock through the patient's body which also shocks the heart.
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
In one embodiment, a carrying case for a wearable cardioverter defibrillator (WCD) is described. The carrying case includes a container with a front wall, a rear wall, and a gusset that couples the front wall to the rear wall. The front wall and rear wall both include multiple fabric layers. Two connection points are inset from an edge of the rear wall. The carrying case also includes an adjustable strap removably coupled to the connection points, and the adjustable strap is configured to be worn in various configurations on a body of a patient.
In further embodiments, the adjustable strap may include a first adjustable section and a second adjustable section. The carrying case may also include a pocket formed on the front wall of the container. The carrying case may also include one or more straps coupled to the rear wall, the straps configured to hold one or more wires. The carrying case may also include a handle coupled to the rear wall. A latching strap may retain a defibrillator in the container. The carrying case may also include one or more adjustable cinchers coupled to the strap. The one or more adjustable cinchers may have a rubber coating. In some embodiments, a quick release coupling attached to the strap. The quick release coupling may have a rubber coating. In some embodiments, a belt clip coupled to the back wall.
In another embodiment, a WCD system is described. The WCD system includes a defibrillator housing. A discharge circuit is in communication with the defibrillator housing, the discharge circuit configured to discharge a stored electrical charge through a body of the patient. A processor is positioned within the defibrillator housing, the processor in communication with the discharge circuit. The WCD system includes a carrying case with a container to hold the defibrillator housing. The carrying case has a front wall, a rear wall, and a gusset coupling the front wall and the rear wall and forming the container. The carrying case also includes each of the front wall and rear wall including multiple fabric layers. The carrying case also includes two connection points inset from an edge of the rear wall. The carrying case also includes an adjustable strap removably coupled to the connection points, the adjustable strap configured to be worn in various configurations on a body of a patient.
In another embodiment, a carrying case for a wearable cardioverter defibrillator is described. The carrying case includes a container with a front wall, a rear wall, and a gusset that couples the front wall to the rear wall. The carrying case also includes each of the front wall and rear wall including multiple fabric layers. The carrying case also includes two connection points inset from an edge of the rear wall. The carrying case also includes an adjustable strap removably coupled to the connection points, the adjustable strap configured to be worn in various configurations on a body of a patient. The carrying case also includes a pocket formed on the front wall of the container. The carrying case also includes one or more straps coupled to the rear wall, the straps configured to hold one or more wires. The carrying case also includes one or more adjustable cinchers coupled to the strap. The carrying case also includes a quick release coupling attached to the strap.
The detailed description set forth below in connection with the appended drawings, where like numerals reference like elements, are intended as a description of various embodiments of the present disclosure and are not intended to represent the only embodiments. Each embodiment described in this disclosure is provided merely as an example or illustration and should not be construed as precluding other embodiments. The illustrative examples provided herein are not intended to be exhaustive or to limit the disclosure to the precise forms disclosed.
In the following description, specific details are set forth to provide a thorough understanding of exemplary embodiments of the present disclosure. It will be apparent to one skilled in the art, however, that the embodiments disclosed herein may be practiced without embodying all of the specific details. In some instances, well-known process steps have not been described in detail in order not to unnecessarily obscure various aspects of the present disclosure. Further, it will be appreciated that embodiments of the present disclosure may employ any combination of features described herein.
Wearable Cardioverter Defibrillators (WCDs) are worn by patients at risk for sudden cardiac arrest (SCA). A patient at risk for SCA are expected to wear or keep the defibrillator in close proximity to their bodies for twenty-four (24) hours a day up to ninety (90) days. That's 2,160 total hours of continuous use. To help patients comply with this request, the carrying pack of the defibrillator must be comfortable but also practical to allow the patient to easily engage with and review the components of the WCD. Therefore, the carrying case of the defibrillator needs to be comfortable, but also allow the patient to access the defibrillator
One of the most important characteristics for a pack to be comfortable while wearing it for such a lengthly time is the ability for the patient to wear the pack in different parts of the body as one position becomes uncomfortable over time or as the patient changes activities. Additionally, people generally have different preferences for where and how they wear packs. The carrying case disclosed herein provides the patient with various positions and styles to wear components of the WCD to ensure the patient continues to use and wear the WCD system.
Previous packs have limited wearability. Typically, they can be worn either over the shoulder or on a belt via a clip. However, the clip design for waste wear is flimsy and does not provide a stable carrying position. The pack flops about as the patient goes about daily activities and can be difficult for people with poor hand mobility to use. Additionally, previous packs are difficult to connect and disconnect the pack's strap.
The pack described in this embodiment provides a carrying case that allows for the patient to wear the pack comfortably on their waist and over their shoulder. The carrying case includes a strap with two adjustable sections. Each section has a strap a length adjuster. The first length adjuster may include a tri-glide that can adjust its strap from a first length to a second length. The second length adjuster may include a free end strap section adjusted by a friction buckle that can be adjusted from a very short first length to a longer length. The carrying case also may include a quick disconnect buckle near the pack that enables it to be quickly and securely taken on and off.
The adjustability of the strap enables the carrying case to hug the patient's body and remain stable during movement. The carrying case insets the connection points in from the outer edge of the pack. As a person's body is roundish shaped, if the straps are attached to the outside of a flat object, the flat object will cause it to rotate and wobble around the body. By insetting the connection points, the strap and the carrying case does not wobble about the body as it is being carrying in such a position.
The carrying case described herein softens features normally hard or potentially rough surfaces which had potentially led to patient discomfort. The carrying case incorporates a rubber coating on the hardware including the snaps, belt clip, D-rings, and tri-glide. The rubber coating makes them softer to the touch, warmer against the skin, and prevents noisy metal on metal clanking noises.
The strap of the carrying pack uses soft nylon webbing for the strap. The nylon webbing provides a comfortable surface that rests against skin. To further increase comfort, the construction of the carrying case hides the attachment of the belt clip and D-rings behind the main body fabric. Therefore, the surface that rests against the patient's skin is smooth.
Referring now to
The support structure 110 may be worn by the patient 102. The support structure 110 may include a vest, shirt, series of straps, or other system enabling the patient 102 to carry at least a portion of the WCD system 104 on the patient's body. In some embodiments, the support structure 110 may comprise a single component. For example, the support structure 110 may comprise a vest or shirt that properly locates the WCD system 104 on a torso 112 of the patient 102. The single component of the support structure 110 may additionally carry or couple to all of the various components of the WCD system 104.
In other embodiments, the support structure 110 may comprise multiple components. For example, the support structure 110 may include a first component resting on a patient's shoulders. The first component may properly locate a series of defibrillation electrodes 114, 116 on the torso 112 of the patient 102. A second component may rest more towards a patient's hips, whereby the second component may be positioned such that the patient's hips support the heavier components of the WCD system 104. For example, the support structure 110 may also include a carrying case 106 to hold components of the WCD system 104 including the defibrillator 108. In some embodiments, the carrying case 106 may be carried via a shoulder, around a waist of the patient 102 or may be kept close to the patient 102 such as in a cart, bag, stroller, wheel chair, or other vehicle.
The external defibrillator 108 may be coupled to the support structure 110 or may be carried remotely from the patient 102. The external defibrillator 108 may be triggered to deliver an electric shock to the patient 102 when patient 102 wears WCD system 104. For example, if certain thresholds are exceeded or met, the external defibrillator 108 may be engaged and deliver a shock to the patient 102.
The WCD system 104 may defibrillate the patient 102 by delivering an electrical charge to the patient 102 through a series of electrodes 114, 116 positioned on the torso 112. The electrodes 114, 116 may be electrically coupled to the external defibrillator 108 via a series of electrode leads 118. The defibrillator 108 may administer an electric shock to the body of the patient 102 when the defibrillation electrodes 114, 116 are in good electrical contact with the torso 112 of patient 102. In some embodiments, devices (not shown) proximate the electrodes 114, 116 may emit a conductive fluid to encourage electrical contact between the patient 102 and the electrodes 114, 116. The electric shock may be a defibrillation shock, which may go through a heart 122 of the patient 102 in an attempt to restart the heart 122. The brief, strong electric pulse may work to restart the heart 122 which may save the patient's life.
Referring to
The latching strap 204 enables a user carry the defibrillator 108 but also view the communication screen, access buttons, and speakers of the defibrillator 108. Likewise, carrying case 106 allows the patient to position the defibrillator 108 such that the screen of the defibrillator 108 may be viewed on either side of the latching strap 204. For example, a right-handed patient may hold the carrying case 106 on their right side and want the screen more visible on the left side of the pack. In other embodiments, a patient may wear the carrying case 106 on their left side and have the screen on a right side to interact with the defibrillator 108.
As shown in
The strap 224 may connect to the rear side 214 of the carrying case 106 at two connection points 222 for connecting a larger strap 224 to the carrying case 106. The connection points 222 may be set in from an edge 226 of the carrying case 106. This may allow the carrying case 106 and the strap 224 to better wrap the bag around a person's waist. For example, by being inset from an edge 226 of the case 106, the strap 224 not try to wrap a flat object around the waist. Instead, the flat portion of the case 106 that contacts the patient's waist is reduce and, coupled with the belt clip, provides a more secure mountain mounting location and a more comfortable wearing configuration.
In some embodiments, the connection points 222 may include two D-rings 225 or other fasteners to couple to the strap 224. In some embodiments, the strap 224 may be removable from the carrying case 106. For example, the strap 224 may have a release mechanism 504 such as snaps, hook and loop, buckles, or other closure types to removably couple to the connection points 222.
In some embodiments, a handle 212 may be located on a rear side 214 of the carrying case 106. The handle 212 may enable the patient to interact with and easily carry the carrying case 106 without using the strap 224.
In some embodiments, the carrying case 106 may include one or more wire straps 230. The wire straps 230 may be positioned in the corner of the carrying case 106. The straps 230 may reach across the rear 214 of the carrying case 106 from a first point 232 on the edge 226 of the carrying case 106 to a second point 234 on a bottom 236 of the carrying case 106. The straps 230 may comprise an elastic material such that the straps 230 may put a tension on any item placed between the strap 230 and the rear side 214 of the carrying case 106. The straps 230 may hold wires or other cords and items associated with the WCD device 104. The straps 230 may hold loose wires from hanging around and getting caught on items or otherwise affected.
As shown in both
Referring now to
Referring back to
In some embodiments, a second portion 514 of the strap 224 may connect to an opposite side of the padded portion 512 and extend to the second strap adjuster 508. The strap adjuster 508 may be an independent component or may be a part of a quick release buckle 516. The quick release buckle 516 may enable the patient to quickly remove and/or place the carrying case 106 in any carrying position.
The strap adjusters 506, 508 may enable the patient to wear the pack 106 in multiple configurations to maximize comfort and therefore conformance. The pack 106 may be worn as a cross-body bag, a waist bag, a simple over the strap, and the like. The ability for the pack 106 to expand and contract enables the patient to change the position of the pack 106 to maximize comfort and change positions throughout the day to match the patient's activities. Furthermore, because the strap 224 is removable, the patient can customize the lengths of the strap 224 to match their body shape.
The processor 702, memory 704 (including software/firmware code (SW) 714), defibrillation port 708, ECG port 710, communication module 716, measurement circuit 718, monitoring device 720, and energy storage module 722 may communicate, directly or indirectly, with one another via one or more buses 724. The one or more buses 724 may allow data communication between the elements and/or modules of the defibrillator 108.
The memory 704 may include random access memory (RAM), read only memory (ROM), flash RAM, and/or other types. The memory 704 may store computer-readable, computer-executable software/firmware code 714 including instructions that, when executed, cause the processor 702 to perform various functions (e.g., determine shock criteria, determine consciousness of patient, track patient parameters, etc.). In some embodiments, the processor 702 may include an intelligent hardware device, e.g., a central processing unit (CPU), a microcontroller, an application-specific integrated circuit (ASIC), etc.
In some embodiments, the memory 704 can contain, among other things, the Basic Input-Output system (BIOS) which may control basic hardware and/or software operations such interactions and workings of the various components of the defibrillator 108, and in some embodiments, components external to the defibrillator 108. For example, the memory 704 may contain various modules to implement the workings of the defibrillator 108, the WCD system, and other aspects of the present disclosure.
In some embodiments, the defibrillator 108 may include a defibrillation port 708. The defibrillation port 708 may comprise a socket, opening, or electrical connection in the housing 712. In some instances, the defibrillation port 708 may include two or more nodes 726, 728. The two or more nodes 726, 728 may accept two or more defibrillation electrodes (e.g. defibrillation electrodes 114, 116,
In some embodiments, the defibrillator 108 may include an ECG port 710 in the housing 712. The ECG port 710 may accept one or more ECG electrodes 730 or ECG leads. In some instances, the ECG electrodes 730 sense a patient's ECG signal. For example, the ECG electrodes 730 may record electrical activity generated by heart muscle depolarization. The ECG electrodes 730 may utilize 7-leads to 12-leads or multichannel ECG, or the like. The ECG electrodes 730 may connect with the patient's skin.
In some embodiments, the defibrillator 108 may include a measurement circuit 718. The measurement circuit 718 may be in communication with the ECG port 710. For example, the measurement circuit 718 may receive physiological signals from ECG port 710. The measurement circuit 718 may additionally or alternatively receive physiological signals via the defibrillation port 708 when defibrillation electrodes 114, 116 are attached to the patient 102. The measurement circuit 718 may determine a patient's ECG signal from a difference in voltage between the defibrillation electrodes 114, 116.
In some embodiments, the measurement circuit 718 may monitor the electrical connection between the defibrillation electrodes 114, 116 and the skin of the patient 102. For example, the measurement circuit 718 can detect impedance between electrodes 114, 116. The impedance may indicate the effective resistance of an electric circuit. An impedance calculation may determine when the electrodes 114, 116 have a good electrical connection with the patient's body.
In some embodiments, the defibrillator 108 may include an internal monitoring device 720 within the housing 712. The monitoring device 720 may monitor at least one local parameter. Local parameters may include physical state of the patient such as ECG, movement, heartrate, pulse, temperature, and the like. Local parameters may also include a parameter of the WCD system (e.g. WCD 104,
In some embodiments, the WCD system 104 may include an internal monitoring device 720 and an external monitoring device (e.g. external monitoring device 124). If both monitoring devices 124, 720 are present, the monitoring devices 124, 720 may work together to parse out specific parameters depending on position, location, and other factors. For example, the external monitoring device 124 may monitor environmental parameters while the internal monitoring device 720 may monitor patient and system parameters.
In some embodiments, the defibrillator 108 may include a power source 732. The power source 732 may comprise a battery or battery pack, which may be rechargeable. In some instances, the power source 732 may comprise a series of different batteries to ensure the defibrillator 108 has power. For example, the power source 732 may include a series of rechargeable batteries as a prime power source and a series of non-rechargeable batteries as a secondary source. If the patient 102 is proximate an AC power source, such as when sitting down, sleeping, or the like, the power source 732 may include an AC override wherein the power source 732 draws power from the AC source.
In some embodiments, the defibrillator 108 may include an energy storage module 722. The energy storage module 722 may store electrical energy in preparation or anticipation of providing a sudden discharge of electrical energy to the patient. In some embodiments, the energy storage module 722 may have its own power source and/or battery pack. In other embodiments, the energy storage module 722 may pull power from the power source 732. In still further embodiments, the energy storage module 722 may include one or more capacitors 734. The one or more capacitors 734 may store an electrical charge, which may be administered to the patient. The processor 702 may be communicatively coupled to the energy storage module 722 to trigger the amount and timing of electrical energy to provide to the defibrillation port 708 and, subsequently, the patient.
In some embodiments, the defibrillator 108 may include a discharge circuit 736. The discharge circuit 736 may control the energy stored in the energy storage module 722. For example, the discharge circuit 736 may either electrical couple or decouple the energy storage module 722 to the defibrillation port 708. The discharge circuit 736 may be communicatively coupled to the processor 702 to control when the energy storage module 722 and the defibrillation port 708 should or should not be coupled to either administer or prevent a charge from emitting from the defibrillator 108. In some embodiments, the discharge circuit 736 may include on or more switches 738. The one or more switches 738 may include an H-bridge.
In some embodiments, the processor 702 may execute one or more modules. For example, the processor 702 may execute a detection module 740 and/or an action module 742. The detection module 740 may be a logic device or algorithm to determine if any or a variety thresholds are exceeded which may require action of the defibrillator 108. For example, the detection module 740 may receive and interpret all of the signals from the ECG port 710, the defibrillation port 708, the monitoring device 720, an external monitoring device, and the like. The detection module 740 may process the information to ensure the patient is still conscious and healthy. If any parameter indicates the patient 102 may be experiencing distress or indicating a cardiac episode, the detection module 740 may activate the action module 742.
The action module 742 may receive data from the detection module 740 and perform a series of actions. For example, an episode may merely be a loss of batter power at the power source 732 or the energy storage module 722, or one or more electrodes (e.g., ECG electrodes, defibrillation electrodes) may have lost connection. In such instances, the action module 742 may trigger an alert to the patient or to an outside source of the present situation. If an episode is a health risk, such as a cardiac event, the action module 742 may begin a series of steps. This may include issuing a warning to the patient, issuing a warning to a third party, priming the energy storage module 722 for defibrillation, releasing one or more conductive fluids proximate defibrillation electrodes 114, 116, and the like.
This document may include references to directions, such as “forward,” “rearward,” “front,” “rear,” “upward,” “downward,” “top,” “bottom,” “right hand,” “left hand,” “lateral,” “medial,” “in,” “out,” “extended,” etc. These references, and other similar references, are only to assist in helping describe and to understand the particular embodiments and are not intended to limit the present disclosure to these directions or locations.
The present document may also reference quantities and numbers. Unless specifically stated, such quantities and numbers are not to be considered restrictive, but exemplary of the possible quantities or numbers associated with the present application. Also in this regard, the present application may use the term “plurality” to reference a quantity or number. The terms “about,” “approximately,” “near,” etc., mean plus or minus 5% of the stated value. For the purposes of the present disclosure, the phrase “at least one of A, B, and C,” for example, means (A), (B), (C), (A and B), (A and C), (B and C), or (A, B, and C), including all further possible permutations when greater than three elements are listed.
The principles, representative embodiments, and modes of operation of the present disclosure have been described in the foregoing description. However, aspects of the present disclosure, which are intended to be protected, are not to be construed as limited to the particular embodiments disclosed. Further, the embodiments described herein are to be regarded as illustrative rather than restrictive. It will be appreciated that variations and changes may be made by others, and equivalents employed, without departing from the spirit of the present disclosure. Accordingly, it is expressly intended that all such variations, changes, and equivalents fall within the spirit and scope of the present disclosure as claimed.
While illustrative embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the disclosure.
This application claims the benefit of U.S. Provisional Application No. 62/677,566 filed May 29, 2018, the disclosure of which is hereby incorporated by reference herein in its entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
3724355 | Busch et al. | Apr 1973 | A |
4411267 | Heyman | Oct 1983 | A |
4583524 | Hutchins | Apr 1986 | A |
4619265 | Morgan et al. | Oct 1986 | A |
4666432 | McNeish et al. | May 1987 | A |
4698848 | Buckley | Oct 1987 | A |
4757804 | Griffith | Jul 1988 | A |
4928690 | Heilman et al. | May 1990 | A |
4955381 | Way et al. | Sep 1990 | A |
5078134 | Heilman et al. | Jan 1992 | A |
5228449 | Christ et al. | Jul 1993 | A |
5348008 | Bornn et al. | Sep 1994 | A |
5353793 | Bornn | Oct 1994 | A |
RE34800 | Hutchins | Nov 1994 | E |
5394892 | Kenny et al. | Mar 1995 | A |
5405362 | Kramer et al. | Apr 1995 | A |
5429593 | Matory | Jul 1995 | A |
5474574 | Payne et al. | Dec 1995 | A |
5577652 | Cooper | Nov 1996 | A |
5618208 | Crouse et al. | Apr 1997 | A |
5662690 | Cole et al. | Sep 1997 | A |
5708978 | Johnsrud | Jan 1998 | A |
5741306 | Glegyak et al. | Apr 1998 | A |
5765735 | Kimchi | Jun 1998 | A |
5782878 | Morgan et al. | Jul 1998 | A |
5792204 | Snell | Aug 1998 | A |
5887777 | Myles | Mar 1999 | A |
5902249 | Lyster | May 1999 | A |
5913685 | Hutchins | Jun 1999 | A |
5944669 | Kaib | Aug 1999 | A |
5960952 | Chen | Oct 1999 | A |
6047203 | Sackner et al. | Apr 2000 | A |
6065154 | Hulings | May 2000 | A |
6108197 | Janik | Aug 2000 | A |
6148233 | Owen et al. | Nov 2000 | A |
6201992 | Freeman | Mar 2001 | B1 |
6263238 | Brewer et al. | Jul 2001 | B1 |
6280461 | Glegyak | Aug 2001 | B1 |
6287328 | Snyder et al. | Sep 2001 | B1 |
6304780 | Owen et al. | Oct 2001 | B1 |
6319011 | Motti et al. | Nov 2001 | B1 |
6334070 | Nova et al. | Dec 2001 | B1 |
6356785 | Snyder et al. | Mar 2002 | B1 |
6427083 | Owen et al. | Jul 2002 | B1 |
6437083 | Brack et al. | Aug 2002 | B1 |
6450942 | Lapanashvili et al. | Sep 2002 | B1 |
6529875 | Nakajima et al. | Mar 2003 | B1 |
6546285 | Owen et al. | Apr 2003 | B1 |
6671545 | Fincke | Dec 2003 | B2 |
6681003 | Linder et al. | Jan 2004 | B2 |
6762917 | Verbiest et al. | Jul 2004 | B1 |
7065401 | Worden | Jun 2006 | B2 |
7559902 | Ting et al. | Jul 2009 | B2 |
7753759 | Pintor et al. | Jul 2010 | B2 |
7865238 | Brink | Jan 2011 | B2 |
7870761 | Valentine et al. | Jan 2011 | B2 |
7974689 | Volpe et al. | Jul 2011 | B2 |
8109421 | McLean | Feb 2012 | B2 |
8135462 | Owen et al. | Mar 2012 | B2 |
8140154 | Donnelly et al. | Mar 2012 | B2 |
8369944 | Macho et al. | Feb 2013 | B2 |
D680324 | Phillips | Apr 2013 | S |
8527028 | Kurzweil et al. | Sep 2013 | B2 |
8548557 | Garstka et al. | Oct 2013 | B2 |
8560044 | Kurzweil et al. | Oct 2013 | B2 |
8615295 | Savage et al. | Dec 2013 | B2 |
8644925 | Volpe et al. | Feb 2014 | B2 |
8676313 | Volpe et al. | Mar 2014 | B2 |
8706255 | Phillips et al. | Apr 2014 | B2 |
8742349 | Urbon et al. | Jun 2014 | B2 |
8897860 | Volpe et al. | Nov 2014 | B2 |
8904214 | Volpe et al. | Dec 2014 | B2 |
8965500 | Macho et al. | Feb 2015 | B2 |
9008801 | Kaib et al. | Apr 2015 | B2 |
9084583 | Mazar et al. | Jul 2015 | B2 |
9089685 | Sullivan et al. | Jul 2015 | B2 |
9119547 | Cazares et al. | Sep 2015 | B2 |
9131901 | Volpe et al. | Sep 2015 | B2 |
9132267 | Kaib | Sep 2015 | B2 |
9265432 | Warren et al. | Feb 2016 | B2 |
9345898 | Piha et al. | May 2016 | B2 |
9408548 | Volpe et al. | Aug 2016 | B2 |
9445719 | Libbus et al. | Sep 2016 | B2 |
9454219 | Volpe et al. | Sep 2016 | B2 |
9579020 | Libbus et al. | Feb 2017 | B2 |
9592403 | Sullivan | Mar 2017 | B2 |
9598799 | Shoshani et al. | Mar 2017 | B2 |
9675804 | Whiting et al. | Jun 2017 | B2 |
9878171 | Kaib | Jan 2018 | B2 |
9895105 | Romem | Feb 2018 | B2 |
9901741 | Chapman et al. | Feb 2018 | B2 |
RE46926 | Bly et al. | Jul 2018 | E |
10016613 | Kavounas | Jul 2018 | B2 |
10076656 | Dar et al. | Sep 2018 | B2 |
10192387 | Brinig et al. | Jan 2019 | B2 |
10307133 | Kaib | Jun 2019 | B2 |
10463867 | Kaib et al. | Nov 2019 | B2 |
10589110 | Oskin et al. | Mar 2020 | B2 |
10599814 | Landrum et al. | Mar 2020 | B2 |
20010027834 | Southwick | Oct 2001 | A1 |
20020162872 | Cascioli | Nov 2002 | A1 |
20020181680 | Linder et al. | Dec 2002 | A1 |
20030158593 | Heilman et al. | Aug 2003 | A1 |
20040148108 | Irish | Jul 2004 | A1 |
20050107833 | Freeman et al. | May 2005 | A1 |
20050107834 | Freeman et al. | May 2005 | A1 |
20060173499 | Hampton et al. | Aug 2006 | A1 |
20080223892 | Hamilton | Sep 2008 | A1 |
20080312709 | Vollpe et al. | Dec 2008 | A1 |
20090005827 | Weintraub et al. | Jan 2009 | A1 |
20090057188 | Kroll | Mar 2009 | A1 |
20100007413 | Herleikson | Jan 2010 | A1 |
20100193559 | Van Huyssteen | Aug 2010 | A1 |
20100298899 | Donnelly et al. | Nov 2010 | A1 |
20110022105 | Owen et al. | Jan 2011 | A9 |
20110288604 | Kaib et al. | Nov 2011 | A1 |
20110288605 | Kaib et al. | Nov 2011 | A1 |
20120112903 | Kaib et al. | May 2012 | A1 |
20120144551 | Guldalian | Jun 2012 | A1 |
20120150008 | Kaib et al. | Jun 2012 | A1 |
20120158075 | Kaib et al. | Jun 2012 | A1 |
20120191476 | Reid et al. | Jul 2012 | A1 |
20120265265 | Razavi et al. | Oct 2012 | A1 |
20120283794 | Kaib et al. | Nov 2012 | A1 |
20120293323 | Kaib et al. | Nov 2012 | A1 |
20120302860 | Volpe et al. | Nov 2012 | A1 |
20120310315 | Savage et al. | Dec 2012 | A1 |
20130085538 | Volpe et al. | Apr 2013 | A1 |
20130144355 | Macho et al. | Jun 2013 | A1 |
20130231711 | Kaib | Sep 2013 | A1 |
20130245388 | Rafferty et al. | Sep 2013 | A1 |
20130274565 | Langer et al. | Oct 2013 | A1 |
20130317852 | Worrell et al. | Nov 2013 | A1 |
20130325078 | Whiting et al. | Dec 2013 | A1 |
20140012144 | Crone | Jan 2014 | A1 |
20140025131 | Sullivan et al. | Jan 2014 | A1 |
20140046391 | Cowan et al. | Feb 2014 | A1 |
20140070957 | Longinotti-Buitoni et al. | Mar 2014 | A1 |
20140163663 | Poddar et al. | Jun 2014 | A1 |
20140303460 | Corley | Oct 2014 | A1 |
20140324112 | Macho et al. | Oct 2014 | A1 |
20140378812 | Saroka et al. | Dec 2014 | A1 |
20150039053 | Kaib et al. | Feb 2015 | A1 |
20150161554 | Sweeney et al. | Jun 2015 | A1 |
20150270728 | Williams | Sep 2015 | A1 |
20150297135 | Shoshani et al. | Oct 2015 | A1 |
20150297904 | Kavounas | Oct 2015 | A1 |
20150328472 | Sullivan et al. | Nov 2015 | A1 |
20160004831 | Carlson et al. | Jan 2016 | A1 |
20160076175 | Rock et al. | Mar 2016 | A1 |
20160076176 | Rock et al. | Mar 2016 | A1 |
20160082277 | Foshee, Jr. et al. | Mar 2016 | A1 |
20160113581 | Amir et al. | Apr 2016 | A1 |
20160166321 | Amsler | Jun 2016 | A1 |
20160256104 | Romem et al. | Sep 2016 | A1 |
20160283900 | Johnson et al. | Sep 2016 | A1 |
20170014073 | Shoshani et al. | Jan 2017 | A1 |
20170027469 | Amir et al. | Feb 2017 | A1 |
20170036066 | Chahine | Feb 2017 | A1 |
20170040758 | Amir et al. | Feb 2017 | A1 |
20170162840 | Pendry | Jun 2017 | A1 |
20170246466 | Murphy | Aug 2017 | A1 |
20170319862 | Foshee, Jr. et al. | Nov 2017 | A1 |
20170367591 | Jorgensen | Dec 2017 | A1 |
20180116537 | Sullivan et al. | May 2018 | A1 |
20180117299 | Gustavson et al. | May 2018 | A1 |
20180184933 | Sullivan et al. | Jul 2018 | A1 |
20180185662 | Foshee, Jr. et al. | Jul 2018 | A1 |
20180243578 | Volosin | Aug 2018 | A1 |
20180361165 | Jaax et al. | Dec 2018 | A1 |
20190030352 | Sullivan et al. | Jan 2019 | A1 |
20190076666 | Medema | Mar 2019 | A1 |
20190116896 | Armour et al. | Apr 2019 | A1 |
20190321650 | Raymond et al. | Oct 2019 | A1 |
Number | Date | Country |
---|---|---|
2005060985 | Jun 2007 | DE |
2305110 | Apr 2011 | EP |
4320257 | Mar 2005 | JP |
5963767 | Jan 2014 | JP |
2014526282 | Oct 2014 | JP |
9839061 | Sep 1998 | WO |
1998039061 | Sep 1998 | WO |
2011146448 | Nov 2011 | WO |
2012064604 | May 2012 | WO |
2012064604 | May 2012 | WO |
WO 2012063196 | May 2012 | WO |
2012151160 | Nov 2012 | WO |
2015056262 | Apr 2015 | WO |
Entry |
---|
Klein, H. U., Goldenberg I., & Moss, A. J., Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update, European Heart Jounal, May 31, 2013, pp. 1-14, doi:10.1093/eurheartj/eht167, European Society of Cardiology. |
Heartstart MRx and XL AED Algorithm—Application Note, Jul. 2001, Edition 2 Phillips Healthcare, USA. |
Zoll LifeVest Model 4000 Patient Manual PN 20B0047 Rev B, (C) 2009-2012. |
LifeVest wearable defibrillator, 2 pages, 2015 ZOLL Medical Corporation, United States. |
Adler, New Drugs and Technologies, Wearable Cardioverter-Defibrillators, Article, 2013 American Heart Association, Inc, pp. 854-860, Tel Aviv University, Tel Aviv, Israel. |
ZOLL LifeVest images, website with images, 2019 ZOLL Medical Corporation, https://lifevest.zoll.com/news/imagery, 4 pages. |
Heartstart MRx and XL AED Algorithm—Application Note, Jul. 2001, Edition 2 Philips Healthcare, USA. |
Klein, H. U., Goldenberg, I., and Moss, A. J., “Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update,” European Heart Journal, May 31, 2013, pp. 1-14, doi:10.1093/eurheartj/eht167, European Society of Cardiology. |
Lifecor LifeVest System Model WCD 3100 Operator's Manual, 2006, PN 20B0040 Rev FI, Zoll Lifecor Corporation, Pittsburgh, PA. |
LifeVest Model 4000 Patient Manual, Zoll, 2009, PN 20B0047 Rev B. |
Pagan-Carlo, et al., “Encircling Overlapping Multipulse Shock Waveforms for Transthoracic Defibrillation,” JACC Journals, Dec. 1998, vol. 32 Issue 7, p. 2065-2071. |
The LifeVest Network/Patient Data Management System, Zoll, 2015, 2000503 Rev A. |
Zoll, LifeVest, Proven protection from Sudden Cardiac Death, issued Mar. 27, 2018, 4 pages. Pittsburgh PA, USA. |
International Search Report and Written Opinion for PCT Application No. PCT/US2015/051726, dated May 20, 2016, European Patent Office, Rijswijk, 11 pages. |
Number | Date | Country | |
---|---|---|---|
20190366110 A1 | Dec 2019 | US |
Number | Date | Country | |
---|---|---|---|
62677566 | May 2018 | US |